ES2117003T3 - Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen. - Google Patents

Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2117003T3
ES2117003T3 ES91830284T ES91830284T ES2117003T3 ES 2117003 T3 ES2117003 T3 ES 2117003T3 ES 91830284 T ES91830284 T ES 91830284T ES 91830284 T ES91830284 T ES 91830284T ES 2117003 T3 ES2117003 T3 ES 2117003T3
Authority
ES
Spain
Prior art keywords
lisil
arginina
aspartil
prolil
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91830284T
Other languages
English (en)
Inventor
Mauro Marzi
Piero Foresta
Patrizia Minetti
Maria Ornella Tinti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2117003T3 publication Critical patent/ES2117003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTAN DERIVADOS DE LA IPOXANTINA DE LA FORMULA GENERAL (I): ASI COMO LAS SALES DE LOS MISMOS CON CATIONES FARMACEUTICAMENTE ACEPTABLES, DONDE N ES UN ENTERO COMPRENDIDO ENTRE 2 Y 6, Y A ES EL RESIDUO DE UN DIPEPTIDO, TRIPEPTIDO, TETRAPEPTIDO Y PENTAPEPTIDO, SELECCIONADO, RESPECTIVAMENTE, ENTRE LOS GRUPOS QUE CONSTAN DE: A) GLICIL-ASPARTATO, ALANIL-GLICINA, GLICIL-GLICINA, ASPARTIL-ARGININA, LEUCIL-ARGININA; B) ARGINIL-LISIL-ASPARTATO, ASPARTIL-LISIL-ARGININA, LISIL-PROLIL-ARGININA, PROLIL-PROLIL-ARGININA, LISIL-ISTIDIL-GLICINAMIDA, PROLIL-FENILANIL -ARGININA, FENILALANIL-PROLIL-ARGININA; C) ARGINIL-LISIL-ASPARTIL-VALINA, VALIL-ASPARTIL-LISIL-ARGININA, TREONIL -VALIL-LEUCIL-HISTIDINA; D) ARGINIL-LISIL-ASPARTIL-VALIL-TIROSINA. LOS DERIVADOS ESTAN DOTADOS CON ACTIVIDAD INMUNOMODULADORA Y PUEDEN SER FORMULADOS EN COMPUESTOS FARMACEUTICOS ADMINISTRABLES ORAL O PARENTERALMENTE.
ES91830284T 1990-06-28 1991-06-26 Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2117003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48102A IT1241452B (it) 1990-06-28 1990-06-28 Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ES2117003T3 true ES2117003T3 (es) 1998-08-01

Family

ID=11264531

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91830284T Expired - Lifetime ES2117003T3 (es) 1990-06-28 1991-06-26 Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.

Country Status (8)

Country Link
US (1) US5298621A (es)
EP (1) EP0464009B1 (es)
JP (1) JPH04230298A (es)
AT (1) ATE166063T1 (es)
DE (1) DE69129387T2 (es)
DK (1) DK0464009T3 (es)
ES (1) ES2117003T3 (es)
IT (1) IT1241452B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110923A (en) * 1994-06-22 2000-08-29 Biochem Pharma Inc. Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
AU717160B2 (en) * 1994-06-22 2000-03-16 Shire Canada Inc. Novel substituted purinyl derivatives with immunomodulating activity
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
DE19541264A1 (de) * 1995-11-06 1997-05-07 Bayer Ag Purin-6-on-derivate
RU2210382C1 (ru) * 2002-07-09 2003-08-20 Терентьев Александр Александрович Пептид, обладающий иммунорегуляторным свойством, и его композиция
KR100721144B1 (ko) * 2006-03-22 2007-05-25 (주)아르떼르화장품 펩타이드 혼합물을 포함하는 주름개선용 화장료 조성물
FR3021319B1 (fr) 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
IT1213495B (it) * 1986-09-17 1989-12-20 Sigma Tau Ind Farmaceuti Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina
IT1223604B (it) * 1987-12-24 1990-09-29 Co Pharma Corp Srl Derivati purinici ad azione farmacologica

Also Published As

Publication number Publication date
JPH04230298A (ja) 1992-08-19
ATE166063T1 (de) 1998-05-15
EP0464009B1 (en) 1998-05-13
IT9048102A0 (it) 1990-06-28
IT9048102A1 (it) 1991-12-28
DE69129387T2 (de) 1998-09-17
EP0464009A2 (en) 1992-01-02
DE69129387D1 (de) 1998-06-18
US5298621A (en) 1994-03-29
DK0464009T3 (da) 1999-03-08
EP0464009A3 (en) 1992-06-17
IT1241452B (it) 1994-01-17

Similar Documents

Publication Publication Date Title
ES2100187T3 (es) Derivados de carboestirilos y composiciones farmaceuticas que los contienen.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
FI930753A0 (fi) Nya fosfolipidderivat av nukleosider, deras framstaellning och deras anvaendning saosom antivirala laekemedel
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
SE8404019L (sv) Oftalmiska antiinflammatoriska medel
ES2057959T3 (es) Derivados de tienopiridina y composiciones farmaceuticas que los contienen.
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE172975T1 (de) Benzimidezolderivate mit antidiabetischer und anti-plättchenklumpungswirkung
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
NO981393D0 (no) Guanidinoproteasehemmere
IL112102A0 (en) Annelated dihydropyridinoacetic acid derivatives, their preparation and pharmaceutical compositions containing them
ES2119874T3 (es) Nuevos derivados de elipticina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
IE893956L (en) Novel compounds
ES2054186T3 (es) Composicion antihepatopatica.
ES2123739T3 (es) Nuevos analogos del eburnano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
HU9500556D0 (en) 15-deoxy-spergualin analogs, process for producing them and use of them for producing pharmaceutical compositions
EA199900684A1 (ru) Производные иминоазаантрациклинона для лечения амилоидоза
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
HUT73786A (en) Nitroxyalkylamide derivatives, process for producing them and pharmaceutical compositions containing them
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464009

Country of ref document: ES